(Press-News.org) Scientists have created a drug for type 2 diabetes that is switched on by blue light, which they hope will improve treatment of the disease.
Diabetes drugs that promote the release of insulin from the pancreas can in some cases cause side effects due to their actions on other organs such as the brain and heart. Some can also stimulate too much insulin release, causing blood sugar levels to drop too low.
To help create better drugs, researchers at Imperial College London and LMU Munich adapted an existing type of drug called a sulfonylurea so that it changes shape when exposed to blue light.
The drug would be inactive under normal conditions, but a patient could in theory switch it on using blue LEDs stuck to the skin. Only a small amount of light would need to penetrate the skin to change the drug's shape and turn it on. This change is reversible, so the drug switches off again when the light goes off.
In a study published today in Nature Communications, the researchers demonstrated that the prototype drug, known as JB253, stimulates insulin release from pancreatic cells in the lab when exposed to blue light.
The study was led by Dr David Hodson and Professor Guy Rutter from the Department of Medicine at Imperial College London, and Professor Dirk Trauner and Dr Johannes Broichhagen at LMU Munich.
Dr Hodson said: "In principle, this type of therapy may allow better control over blood sugar levels because it can be switched on for a short time when required after a meal. It should also reduce complications by targeting drug activity to where it's needed in the pancreas".
"So far, we've created a molecule that has the desired effect on human pancreatic cells in the lab. There's a long way to go before a therapy is available to patients, but this remains our ultimate goal."
Type 2 diabetes affects around 350 million people worldwide. It impairs people's control over their blood sugar levels, leading to higher risk of heart disease and stroke and potentially causing damage to the kidneys, nerves and retinas.
Although molecules that react to light have been known about since the 19th century, only in the last few years have scientists exploited their properties to make light-sensitive molecules with drug effects.
"Photoswitchable drugs and photopharmacology could be enormously useful for all sorts of diseases, by allowing remote control over specific body processes with light," said Professor Trauner.
The research was funded by Diabetes UK, the European Foundation for the Study of Diabetes, the European Research Council, the Wellcome Trust and the Medical Research Council.
Dr Richard Elliott, from Diabetes UK, said: "Sulfonylureas help many people to manage type 2 diabetes even though, like other medications, they can have side effects. Work on light-activated medications is still at a relatively early stage, but this is nevertheless a fascinating area of study that, with further research, could help to produce a safer, more tightly-controllable version of this important therapy."
INFORMATION:
For more information please contact:
Sam Wong
Research Media Officer
Imperial College London
Email: sam.wong@imperial.ac.uk
Tel: +44(0)20 7594 2198
Out of hours duty press officer: +44(0)7803 886 248
Notes to editors:
Reference: Johannes Broichhagen et al. 'Optical control of insulin release using a photoswitchable sulfonylurea.' Nature Communications, 14 October 2014. DOI: 10.1038/ncomms6116
About diabetes
1. In the UK, there are around 3.8 million people who have diabetes. There are 3.2 million people living with Type 1 and Type 2 diabetes, and around 630,000 more who have Type 2 diabetes but don't know they have it because they haven't been diagnosed. As many as 7 million people are at high risk of developing Type 2 diabetes and if current trends continue, an estimated 5 million people will have diabetes by 2025.
2. Diabetes is a condition where there is too much glucose in the blood because the body cannot use it properly. If not managed well, both Type 1 and Type 2 diabetes can lead to devastating complications. Diabetes is the leading cause of blindness in people of working age in the UK and is a major cause of lower limb amputation, kidney failure and stroke.
3. People with Type 2 diabetes don't produce enough insulin or the insulin they produce doesn't work properly (known as insulin resistance). 85 to 90 per cent of people with diabetes have Type 2. They might get Type 2 diabetes because of their family history, age and ethnic background puts them at increased risk. They are also more likely to get Type 2 diabetes if they are overweight. It starts gradually, usually later in life, and it can be years before they realise they have it. Type 2 diabetes is treated with a healthy diet and increased physical activity. In addition, tablets and/or insulin can be required.
4. For more information on reporting on diabetes, download Diabetes UK's guide for journalists: http://www.diabetes.org.uk/journalists-guide
About Imperial College London
Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.
Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges.
In 2007, Imperial College London and Imperial College Healthcare NHS Trust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible.
http://www.imperial.ac.uk
Light-activated drug could reduce side effects of diabetes medication
2014-10-14
ELSE PRESS RELEASES FROM THIS DATE:
New forecasting method: Predicting extreme floods in the Andes mountains
2014-10-14
This might allow for improved disaster preparedness. As the complex systems technique builds upon a mathematical comparison that can be utilised for any time series data, the approach could be applied to extreme events in all sorts of complex systems.
"Current weather forecast models cannot capture the intensity of the most extreme rainfall events, yet these events are of course the most dangerous, and can have severe impacts for the local population, for example major floods or even landslides," says lead author Niklas Boers of the Potsdam Institute for Climate Impact ...
Teenage baseball pitchers at risk for permanent shoulder injury
2014-10-14
OAK BROOK, Ill. – Young baseball pitchers who throw more than 100 pitches per week are at risk for a newly identified overuse injury that can impede normal shoulder development and lead to additional problems, including rotator cuff tears, according to a new study published online in the journal Radiology.
The injury, termed acromial apophysiolysis by the researchers, is characterized by incomplete fusion and tenderness at the acromion. The acromion, which forms the bone at the top or roof of the shoulder, typically develops from four individual bones into one bone ...
New clues behind the resilience of a leading sexually transmitted pathogen, Chlamydia
2014-10-14
In the advanced online edition of Molecular Biology and Evolution, authors Domman, et al. have explored factors behind the resilience of the most common sexually transmitted disease in the U.S., chlamydia, with an estimated 1 million infected.
The research team sequenced 4 new strains of close genetic cousins of chlamydial pathogens, and examined these with existing DNA data. They found an extensive and robust shuffling of the genomic deck between chlamydia families has played a major role in the evolution of the pathogen, often serving to outwit and exploit its hosts. ...
Study sheds light on factors that may contribute to pancreatic cancer
2014-10-14
New research that provides a better understanding of pancreatic cancer may help identify individuals at increased risk. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Pancreatic cancer is a stealthy cancer that is usually detected at very late stages and has a 5-year survival rate of less than 5 percent. Strategies that might help identify which individuals have an increased risk of developing the disease are sorely needed. Some cases seem to run in families, but the genes that are responsible for such inherited ...
Slow enteral feeding protocol can reduce instances of death in extreme preterm infants
2014-10-14
A standardized slow enteral feeding (SSEF) protocol significantly reduces the incidence of necrotizing enterocoltis (NEC), or death of intestinal tissue, and death in infants with extremely low birth weight, according to a new study.
The study, published today in the OnlineFirst version of the Journal of Parenteral and Enteral Nutrition (JPEN), the research journal of the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), found the use of SSEF resulted in a significant reduction in NEC and accompanying death in infants with a birth weight below 750 grams ...
Memories of pain during childbirth tied to intensity rather than length of labor
2014-10-14
Childbirth is physically intense and, for many women, it is the most painful experience they will have. And yet, new research shows that the amount of time a woman spends in labor doesn't seem to impact how she remembers her labor pain afterwards. The research, published in Psychological Science, a journal of the Association for Psychological Science, reveals that the peak and end levels of pain women experienced, and whether they received an epidural, impacted their recall of labor pain afterward.
"This phenomenon – called duration neglect – is particularly ...
Fly genome could help us improve health and our environment
2014-10-14
The house fly might be a worldwide pest, but its genome will provide information that could improve our lives. From insights into pathogen immunity, to pest control and decomposing waste, the 691 Mb genome has been sequenced and analyzed by a global consortium of scientists, and is published in the open access journal Genome Biology.
The genome highlights detoxification and immune system genes that are unique to the insect, and could be subjects of further study to help humans deal with toxic and disease causing environments.
The house fly (Musca domestica) lives on ...
Sonic Hedgehog protein causes DNA damage and the development child brain tumors
2014-10-14
Scientists at the IRCM and the University of Montreal discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Frédéric Charron, PhD, found that a protein known as Sonic Hedgehog induces DNA damage, which causes the cancer to develop. This important breakthrough will be published in the October 13 issue of the prestigious scientific journal Developmental Cell. The editors also selected the article to be featured on the journal's cover.
Sonic Hedgehog belongs to a family of proteins ...
Cautious optimism as childhood obesity rates in Ireland plateau
2014-10-14
Childhood overweight and obesity rates have plateaued in primary school aged children in the Republic of Ireland, reveals research published today in the open access journal BMC Public Health. The study found that although obesity rates remain high, there is evidence that they have stabilised and may be beginning to fall.
During the last three decades of the 20th century, a two to three fold increase in overweight and obesity prevalence in school age children was reported across regions in North America and Western Europe. It was estimated that by the year 2000, 25-33% ...
Stenting safe and effective for long-term stroke prevention
2014-10-14
Using stents to keep neck arteries open is just as effective as invasive neck surgery for long-term prevention of fatal and disabling strokes, reports an international trial led by UCL (University College London) funded by the Medical Research Council and Stroke Association.
The research paper, published today in the Lancet, was authored by researchers from UCL, Basel University, Switzerland, the London School of Hygiene & Tropical Medicine, the University Medical Center Utrecht, Netherlands, Sheffield Teaching Hospitals NHS Foundation Trust, and Newcastle University.
The ...